losartan has been researched along with thiazolyl blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YQ; Jia, Y; Li, XH; Liu, Y; Wang, XQ; Zhang, HG; Zhou, JZ | 1 |
| Ji, Z; Qiu, G | 1 |
2 other study(ies) available for losartan and thiazolyl blue
| Article | Year |
|---|---|
Gαq-protein carboxyl terminus imitation polypeptide GCIP-27 attenuates proliferation of vascular smooth muscle cells and vascular remodeling in spontaneously hypertensive rats.
Topics: 3T3 Cells; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Blood Pressure; Blood Pressure Determination; Calcium; Cardiotonic Agents; Cell Culture Techniques; Cell Proliferation; Collagen; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; GTP-Binding Protein alpha Subunits, Gq-G11; Hypertension; Hypertrophy; Losartan; Male; Mice; Molecular Targeted Therapy; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Peptides; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Tetrazolium Salts; Thiazoles; Type C Phospholipases; Vasoconstrictor Agents | 2011 |
AngII-induced glomerular mesangial cell proliferation inhibited by losartan via changes in intracellular calcium ion concentration.
Topics: Angiotensin II; Blotting, Western; Calcium; Cations, Divalent; Cell Line; Cell Proliferation; Cytoplasm; Gene Expression Profiling; Humans; Losartan; Mesangial Cells; Microscopy, Confocal; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling; Tetrazolium Salts; Thiazoles; TRPC Cation Channels; TRPC6 Cation Channel; Trypan Blue | 2014 |